Oral THC Drug Tests Were Mostly Negative by Morning After Evening Medicinal Cannabis

At 30 minutes post-dose, oral fluid THC concentrations varied widely (0-425 ng/mL), and both devices showed poor sensitivity (Securetec: 25%, Drager: 50%). By 10 and 18 hours post-treatment, all participants had THC concentrations below screening cutoffs and all test results were negative. The finding suggests low probability of a positive next-morning test after one-off oral medicinal cannabis use.

Randomized, double-blind, crossover trial. 20 adults with insomnia received a single oral dose of 10mg THC + 200mg CBD oil or placebo before sleep. Point-of-collection testing with Securetec DrugWipe 5S (10 ng/mL cutoff) and Drager DrugTest 5000 (25 ng/mL cutoff) at baseline, 0.5h, 10h, and 18h post-dose. LC-MS/MS confirmation at each time point.

Patients using medicinal cannabis for sleep worry about failing workplace or roadside drug tests the next day. This study provides evidence that a standard oral dose is unlikely to produce a positive result the morning after, though it also reveals that current testing devices poorly detect oral cannabis use even shortly after dosing.

The dual finding is important: roadside oral fluid tests poorly detect oral medicinal cannabis (unlike smoked cannabis which deposits THC directly in the mouth), and next-morning tests are very unlikely to be positive. This has implications for both law enforcement and patient reassurance.

Small sample (n=20). Only one oral dose tested; regular nightly use might produce cumulative detection. Only two testing devices evaluated. The wide variability at 0.5h (0-425 ng/mL) suggests individual pharmacokinetic differences that could affect detection with regular use.